Aligos Therapeutics, Inc. (NASDAQ:ALGS) Sees Large Drop in Short Interest
MarketBeatAligos Therapeutics, Inc. (NASDAQ:ALGS – Get Free Report) was the target of a large decrease in short interest in October. As of October 15th, there was short interest totalling 82,800 shares, a decrease of 31.0% from the September 30th total of 120,0…